Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA Expands Use of T-DXd in Early HER2+ Breast Cancer

2.

The combination of nitedanib and prednisone reduces exacerbations of pulmonary diseases in radiative pneumonitis

3.

The Predictive Power of Liquid Biopsy in Colon Cancer Outcomes Is Inconsistent.

4.

Why palliative care goes hand in hand with treatment for people with cancer: Q&A

5.

Prostate cancer relapse after radiotherapy is strongly predicted by biological markers.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot